GNPNAT1 was only reported in prostate cancer, which was suggested to be over-expressed in prostate cancer tissue (Ren et al., 2016) and to be connected with the development of castrationresistant prostate cancer (Kaushik et al., 2016). Here, GNPNAT1 is linked to prostate cancer.